Sequencing the New Horizon in Clinical Molecular Diagnostics

Sequencing the New Horizon in Clinical Molecular Diagnostics

Non-infectious disease molecular assays represent approximately only 1% of the global in vitro diagnostics (IVD) market , but are recognized by nearly every significant industry player as the most promising diagnostics area in terms of market development and future growth. IVD-leading growth in molecular diagnostics is fueled by genomic discovery and gradually improving coverage under health insurance (not without some hiccups, namely molecular procedure recoding). Not since the commercializatio...


Ionizing Tea Leaves - Kalorama Explores the Future of Clinical Mass Spectometry

Ionizing Tea Leaves - Kalorama Explores the Future of Clinical Mass Spectometry

The sophistication and analytical flexibility of mass spectrometry systems traditionally excluded them from routine clinical diagnostics. Today, mass spectrometry and its derivative technologies - gas chromatography mass spectrometry (GC-MS), liquid chromatography mass spectrometry (LC-MS), liquid chromatography tandem mass spectrometry (LC-MS/MS), and others - are seeing increasingly wider usage in healthcare. Led by the rising application of matrix-assisted laser desorption/ionization time-of-...


The Hungry Dragon - China in the Global Clinical Nutrition Market

The Hungry Dragon - China in the Global Clinical Nutrition Market

China has yet to claim first or second billing in most major clinical or healthcare product markets, despite its exceptional economic growth, heavy public-private mix in healthcare investment, and its roughly 1.4 billion residents. China’s potential is already evident in clinical nutrition with Kalorama Information estimating it to be the second largest national market. Clinical nutrition products include infant formulas (powdered, liquid concentrate, ready-to-drink), enteral nutrition formulas ...


Veterinary Diagnostics - Epidemiological Update

Veterinary Diagnostics - Epidemiological Update

In Kalorama Information’s last edition of its veterinary diagnostics market study , bovine viral diarrhea (BVD) was estimated to be among the largest food animal infectious disease test markets in the world. The global BVD test market has grown in the past decade largely through European BVD disease control and eradication efforts; the United States has yet to implement a BVD control program nationwide with only regional voluntary programs active. The current state of BVD control activities is i...

  • by bcarlson@marketresearch.com
  • August 18 2014


IVD Market $54 Billion: Kalorama’s 9th Edition Report

IVD Market $54 Billion: Kalorama’s 9th Edition Report

The world market for diagnostics is estimated at $54.6 billion in 2013, according to Kalorama Information. Kalorama revealed the market estimate in its biennial survey of the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests, 9 th Edition. Aside this article is a Wordle of the entire text of the report, which provides some indication of the topics that are most often discussed in its pages. The survey can be obtained at http://www.kaloramainformation.com/Worldwide-Vitro-Diagnostic...


Recent FDA Guidance Benefits IVD Companies in Companion Diagnostics

Recent FDA Guidance Benefits IVD Companies in Companion Diagnostics

On July 31, the U.S. Food and Drug Administration (FDA) issued its finalized guidance on companion diagnostics and an oversight framework for lab-developed tests (LDTs), which have so far escaped the regulatory scrutiny visited on in vitro diagnostic (IVD) tests. The greatest impact of the FDA’s recent release will fall in companion diagnostics (also known as pharmacodiagnostics) or tests that inform clinicians of the efficacy or benefit of a pharmaceutical based on the genetics of an individual...

  • by bcarlson@marketresearch.com
  • August 6 2014


Cerner-Siemens AG Deal Shakes Up EMR Market

Cerner-Siemens AG Deal Shakes Up EMR Market

Cerner Corporation and Siemens AG’s announcement that Cerner will acquire the assets of Siemens’ health information technology business unit, Siemens Health Services, for $1.3 billion creates scale for future industry innovation, given the combined $650 million annual R&D investment the deal entails. As covered in our EMR market report earlier this year, Siemens is one of the companies that has moved away from electronic medical records in favor of other systems. The move should help Cerner buil...


Grassroots Molecular - How AACC Exhibitors Addressed the New Frontier in POC and Decentralized Testing

Grassroots Molecular - How AACC Exhibitors Addressed the New Frontier in POC and Decentralized Testing

Kalorama Information recently attended the 2014 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in Chicago. The following post details one front of market expansion in clinical diagnostics - relatively low complexity molecular testing platforms able to be deployed in various healthcare settings.

Even after a relatively disappointing year for molecular diagnostics overall in 2013 , industry remains poised to capitalize on remaining underserved areas of de...